<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>24(2)</volume><submitter>El Malti R</submitter><pubmed_abstract>The etiology of congenital heart defect (CHD) combines environmental and genetic factors. So far, there were studies reporting on the screening of a single gene on unselected CHD or on familial cases selected for specific CHD types. Our goal was to systematically screen a proband of familial cases of CHD on a set of genetic tests to evaluate the prevalence of disease-causing variant identification. A systematic screening of GATA4, NKX2-5, ZIC3 and Multiplex ligation-dependent probe amplification (MLPA) P311 Kit was setup on the proband of 154 families with at least two cases of non-syndromic CHD. Additionally, ELN screening was performed on families with supravalvular arterial stenosis. Twenty-two variants were found, but segregation analysis confirmed unambiguously the causality of 16 var</pubmed_abstract><journal>European journal of human genetics : EJHG</journal><pagination>228-36</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4717196</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A systematic variant screening in familial cases of congenital heart defects demonstrates the usefulness of molecular genetics in this field.</pubmed_title><pmcid>PMC4717196</pmcid><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Cordier-Alex MP</pubmed_authors><pubmed_authors>Heitz F</pubmed_authors><pubmed_authors>Teboul M</pubmed_authors><pubmed_authors>Ducreux C</pubmed_authors><pubmed_authors>Bouvagnet P</pubmed_authors><pubmed_authors>Doray B</pubmed_authors><pubmed_authors>Acar P</pubmed_authors><pubmed_authors>Vigneron J</pubmed_authors><pubmed_authors>Marcon F</pubmed_authors><pubmed_authors>Gronier C</pubmed_authors><pubmed_authors>Sanlaville D</pubmed_authors><pubmed_authors>Lusson JR</pubmed_authors><pubmed_authors>Thauvin C</pubmed_authors><pubmed_authors>Bonnet D</pubmed_authors><pubmed_authors>Maltret A</pubmed_authors><pubmed_authors>Roume J</pubmed_authors><pubmed_authors>El Malti R</pubmed_authors><pubmed_authors>Goncalves-Rocha M</pubmed_authors><pubmed_authors>Beyler C</pubmed_authors><pubmed_authors>Dauphin C</pubmed_authors><pubmed_authors>Blanchet P</pubmed_authors><pubmed_authors>Veyrier M</pubmed_authors><pubmed_authors>Levy M</pubmed_authors></additional><is_claimable>false</is_claimable><name>A systematic variant screening in familial cases of congenital heart defects demonstrates the usefulness of molecular genetics in this field.</name><description>The etiology of congenital heart defect (CHD) combines environmental and genetic factors. So far, there were studies reporting on the screening of a single gene on unselected CHD or on familial cases selected for specific CHD types. Our goal was to systematically screen a proband of familial cases of CHD on a set of genetic tests to evaluate the prevalence of disease-causing variant identification. A systematic screening of GATA4, NKX2-5, ZIC3 and Multiplex ligation-dependent probe amplification (MLPA) P311 Kit was setup on the proband of 154 families with at least two cases of non-syndromic CHD. Additionally, ELN screening was performed on families with supravalvular arterial stenosis. Twenty-two variants were found, but segregation analysis confirmed unambiguously the causality of 16 var</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Feb</publication><modification>2025-04-26T16:22:15.75Z</modification><creation>2019-03-27T02:07:06Z</creation></dates><accession>S-EPMC4717196</accession><cross_references><pubmed>26014430</pubmed><doi>10.1038/ejhg.2015.105</doi></cross_references></HashMap>